Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

We estimate the company's R&D expense to increase 11.2% in 2025. Globus Medical has merged its business with NuVasive. The combined global musculoskeletal company is focused on rapid innovation ...

AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended ...

The upcoming report from Globus Medical (GMED) is expected to reveal quarterly earnings of $0.74 per share, indicating an increase of 2.8% compared to the year-ago period. Analysts forecast ...

NuVasive infringed five patents from a spine surgeon, a jury determined, according to an April 22 report from Bloomberg Law. The jury ruled that screw assemblies from the Reline, Armada and VuePoint ...

AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March ...

Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

In the past year, this Zacks Rank #3 (Hold) stock has rallied 38.1% against the industry’s 7.4% fall and the S&P 500 composite’s 9.1% rise. The renowned medical device company has a market ...